Pharmarise Holdings (TSE:2796) Beneish M-Score: -2.91 (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2796 Pharmarise Holdings Corp TSE:2796
50 GF Score
Price 円491.00
GF Value 円608.07
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Pharmarise Holdings Beneish M-Score?

Pharmarise Holdings TSE:2796 -0.61% 50 Beneish M-Score is -2.91 as of Jul. 22, 2026. GuruFocus rates TSE:2796 with a GF Score™ of 50/100 and a GF Value™ of 円608.07 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 628 Healthcare Providers & Services companies, Pharmarise Holdings ranks better than 75.64% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.91 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Pharmarise Holdings's Beneish M-Score or its related term are showing as below:

TSE:2796' s Beneish M-Score Range Over the Past 10 Years
Min: -3.22   Med: -2.77   Max: -2.22
Current: -2.91

During the past 13 years, the highest Beneish M-Score of Pharmarise Holdings was -2.22. The lowest was -3.22. And the median was -2.77.


Pharmarise Holdings Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Pharmarise Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmarise Holdings Beneish M-Score Chart

Pharmarise Holdings Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.22 -2.98 -2.98 -2.59 -2.91

Pharmarise Holdings Semi-Annual Data
Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25 May26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.98 0.00 -2.59 0.00 -2.91

Pharmarise Holdings Beneish M-Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, Pharmarise Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmarise Holdings Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharmarise Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Pharmarise Holdings's Beneish M-Score falls into.


TSE:2796
50GF Score
Pharmarise Holdings Corp TSE:2796
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmarise Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Pharmarise Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9064+0.528 * 1.0374+0.404 * 1.0125+0.892 * 1.0945+0.115 * 0.9862
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.096818-0.327 * 1.0088
=-2.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (May26) TTM:Last Year (May25) TTM:
Total Receivables was 円3,758 Mil.
Revenue was 円69,512 Mil.
Gross Profit was 円9,459 Mil.
Total Current Assets was 円13,164 Mil.
Total Assets was 円32,680 Mil.
Property, Plant and Equipment(Net PPE) was 円7,621 Mil.
Depreciation, Depletion and Amortization(DDA) was 円1,605 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円14,010 Mil.
Long-Term Debt & Capital Lease Obligation was 円10,227 Mil.
Net Income was 円114 Mil.
Gross Profit was 円0 Mil.
Cash Flow from Operations was 円3,278 Mil.
Total Receivables was 円3,788 Mil.
Revenue was 円63,508 Mil.
Gross Profit was 円8,965 Mil.
Total Current Assets was 円13,239 Mil.
Total Assets was 円31,924 Mil.
Property, Plant and Equipment(Net PPE) was 円7,209 Mil.
Depreciation, Depletion and Amortization(DDA) was 円1,493 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円11,988 Mil.
Long-Term Debt & Capital Lease Obligation was 円11,482 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3758 / 69512) / (3788 / 63508)
=0.054063 / 0.059646
=0.9064

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(8965 / 63508) / (9459 / 69512)
=0.141163 / 0.136077
=1.0374

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (13164 + 7621) / 32680) / (1 - (13239 + 7209) / 31924)
=0.363984 / 0.359479
=1.0125

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=69512 / 63508
=1.0945

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1493 / (1493 + 7209)) / (1605 / (1605 + 7621))
=0.17157 / 0.173965
=0.9862

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 69512) / (0 / 63508)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((10227 + 14010) / 32680) / ((11482 + 11988) / 31924)
=0.741646 / 0.735184
=1.0088

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(114 - 0 - 3278) / 32680
=-0.096818

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Pharmarise Holdings has a M-score of -2.91 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.91 mean?
Pharmarise Holdings (TSE:2796) has a Beneish M-Score of -2.91 as of Jul. 22, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Pharmarise Holdings and its competitors. According to the industry distribution chart, Pharmarise Holdings ranks #153 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 24.4%.
Is Pharmarise Holdings' Beneish M-Score too high?
Pharmarise Holdings' current Beneish M-Score is -2.91. Based on the distribution chart, Pharmarise Holdings ranks #153 out of 628 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pharmarise Holdings has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharmarise Holdings' Beneish M-Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Pharmarise Holdings ranks #153 out of 628 companies for Beneish M-Score. This places Pharmarise Holdings in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Pharmarise Holdings and its competitors. Pharmarise Holdings's current Beneish M-Score is -2.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmarise Holdings stock overvalued right now?
Based on GuruFocus' analysis, Pharmarise Holdings (TSE:2796) is currently considered Modestly Undervalued. The stock's GF Value™ is 円608.07, compared to a current price of 円491.00 — trading 19.3% below its estimated fair value. The current Beneish M-Score is -2.91. Pharmarise Holdings' overall GF Score™ is 50/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Pharmarise Holdings (TSE:2796), the current Beneish M-Score is -2.91 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmarise Holdings (TSE:2796) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmarise Holdings stock appears to be undervalued. The current stock price of 円491.00 is trading 19.3% below its estimated GF Value™ of 円608.07. GuruFocus considers Pharmarise Holdings to be Modestly Undervalued.

Key valuation signals for TSE:2796:

  • Beneish M-Score: -2.91
  • GF Value™: 円608.07 vs. price of 円491.00 (19.3% below fair value)
  • GF Score™: 50/100 with 10 warning signs

No single metric tells the full story. See the TSE:2796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharmarise Holdings Business Description

Address 8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on the prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.
50GF Score

Get the complete analysis for TSE:2796

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円491.00
Price
円608.07
GF Value